Advisor OS LLC lessened its stake in Chemed Co. (NYSE:CHE - Free Report) by 49.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 542 shares of the company's stock after selling 528 shares during the quarter. Advisor OS LLC's holdings in Chemed were worth $287,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in CHE. HighTower Advisors LLC grew its holdings in Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock valued at $2,246,000 after purchasing an additional 1,634 shares during the last quarter. XTX Topco Ltd grew its stake in Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock valued at $1,709,000 after acquiring an additional 1,499 shares during the last quarter. Geode Capital Management LLC grew its stake in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after acquiring an additional 15,791 shares during the last quarter. Signal Advisors Wealth LLC increased its holdings in Chemed by 60.7% during the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock valued at $2,647,000 after acquiring an additional 1,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Chemed by 8.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company's stock worth $73,792,000 after acquiring an additional 9,178 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.
Wall Street Analyst Weigh In
CHE has been the topic of several research reports. StockNews.com lowered shares of Chemed from a "buy" rating to a "hold" rating in a research report on Thursday. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research report on Tuesday, November 5th.
View Our Latest Stock Analysis on CHE
Chemed Trading Down 2.0 %
Shares of NYSE CHE traded down $11.87 during midday trading on Monday, reaching $588.93. 178,604 shares of the stock were exchanged, compared to its average volume of 98,255. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The stock has a 50 day moving average price of $546.69 and a 200-day moving average price of $563.35. The company has a market capitalization of $8.86 billion, a P/E ratio of 29.76, a P/E/G ratio of 2.15 and a beta of 0.48.
Chemed Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed's payout ratio is currently 10.05%.
Insider Buying and Selling
In other news, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction dated Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares of the company's stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.32% of the company's stock.
Chemed Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.